Dapeng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Best Researcher Award

Dapeng Chen
Zeteo Tech, Inc, United States

                 Dapeng Chen
Affiliation Zeteo Tech, Inc.
Country United States
Scopus ID 57201295454
Documents 12
Citations 132
h-index 7
Subject Area Biochemistry, Genetics and Molecular Biology
Event Global Innovation Technologist Awards

The Best Researcher Award profile presents Dapeng Chen’s reported scholarly output and research activity in the context of the Global Innovation Technologist Awards. Associated with Zeteo Tech, Inc., in the United States, Chen is listed under Biochemistry, Genetics and Molecular Biology. The available bibliometric information records 12 documents, 132 citations and an h-index of 7. These indicators provide a quantitative overview of indexed research activity and offer context for examining publication contributions and scholarly influence. [1]

Abstract

This article summarizes the available research-profile information for Dapeng Chen and highlights a reported publication titled digitalMALDI: A Single-Particle–Based Mass Spectrometric Detection System for Biomolecules, published in 2025 in the Journal of Mass Spectrometry. The study title indicates a focus on mass spectrometric detection of biomolecules using a single-particle-based system. The supplied record also reports 12 documents, 132 citations and an h-index of 7. The profile offers a starting point for reviewing research output, while detailed evaluation requires examination of the full publication record and verified author information. [2]

Keywords

Dapeng Chen; mass spectrometry; digitalMALDI; biomolecule detection; single-particle analysis; biochemistry; molecular biology; research impact; scientific publications; researcher recognition.

Introduction

Researcher profiles help organize scholarly publications and citation information across disciplines. In biochemistry and molecular biology, analytical techniques such as mass spectrometry contribute to the detection and characterization of biological molecules. Chen’s reported 2025 publication on digitalMALDI provides a specific research topic through which to explore this broader area. Assessment should distinguish bibliometric indicators from direct evidence of methodological quality, reproducibility and practical significance. [2]

Research Profile

The supplied profile identifies Chen’s institutional affiliation as Zeteo Tech, Inc., and lists the United States as the associated country. The reported Scopus author identifier is 57201295454. The record contains 12 documents and 132 citations, with an h-index of 7. The h-index combines publication productivity and citation frequency, but does not independently establish research quality or the contribution of any individual paper. Figures can also change as databases update their records. [1]

Research Contributions

The supplied publication title identifies a single-particle-based mass spectrometric detection system for biomolecules. This topic connects analytical instrumentation with biological analysis and suggests an interest in methods for detecting molecular targets. Establishing the system’s actual performance, sensitivity, selectivity and limitations requires consultation of the full article and its experimental results. The title alone is not sufficient to make claims about clinical use or validated diagnostic performance. [2]

Publications

One publication supplied for this profile is listed below. The provided author information includes Dapeng Chen, Wayne A. Bryden, Michael McLoughlin and Kyle M. Regan, among other contributors, with Lara P. Moore also identified in the author listing. The complete author order and bibliographic metadata should be checked against the publisher’s record before formal citation.

  • digitalMALDI: A Single-Particle–Based Mass Spectrometric Detection System for Biomolecules. Journal of Mass Spectrometry, 2025. DOI: not supplied in the provided record. [2]

Research Impact

The reported 132 citations suggest that Chen’s indexed publications have received scholarly attention. The h-index of 7 indicates that seven publications have at least seven citations each, provided the supplied value follows the standard definition and reflects a consistent database snapshot. Citation counts vary by source, field and publication age; they should therefore be interpreted alongside research content, authorship contributions and independent evidence of influence. [1]

Award Suitability

The Global Innovation Technologist Awards provides the recognition context for this profile. Chen’s reported publication activity and work related to biomolecule detection may be considered as part of a broader assessment of research contributions. A fair award evaluation should examine verified publications, originality, methodological rigor, individual contribution and relevance to the stated category. The available information does not establish an award decision or independently confirm eligibility.

Conclusion

Dapeng Chen’s supplied research profile records 12 documents, 132 citations and an h-index of 7, alongside a 2025 publication concerning single-particle-based mass spectrometric detection of biomolecules. These details provide a concise overview of the reported scholarly record. Verification through authoritative databases and examination of the original publication remain important steps in establishing bibliographic accuracy and assessing the significance of the research.

References

  1. Elsevier. (n.d.). Scopus author details: Dapeng Chen, Author ID 57201295454. Scopus. Bibliometric figures in this article are based on the supplied profile information and should be rechecked against the live record.
    https://www.scopus.com/authid/detail.uri?authorId=57201295454
  2. Journal of Mass Spectrometry. (2025). digitalMALDI: A Single-Particle–Based Mass Spectrometric Detection System for Biomolecules. Publication details supplied for this profile.
  3. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com

MEHMET KIVRAK | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

MEHMET KIVRAK
Affiliation Recep Tayyip Erdogan University
Country Turkey
Scopus ID 57211715569
Documents 22
Citations 92
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-2405-8552

MEHMET KIVRAK

Recep Tayyip Erdogan University, Turkey

MEHMET KIVRAK is a researcher affiliated with Recep Tayyip Erdogan University whose scholarly work focuses on Biology and Life Sciences with interdisciplinary applications in clinical medicine, women’s health, artificial intelligence-assisted healthcare, and biomarker discovery. His research portfolio demonstrates consistent contributions to observational clinical studies and translational biomedical investigations published in peer-reviewed international journals.[1]

Abstract

This article summarizes the academic profile of MEHMET KIVRAK in relation to the Innovative Research Award. His published work spans clinical medicine, reproductive health, inflammatory biomarkers, cardiovascular risk assessment, and explainable artificial intelligence. The available publication record indicates sustained engagement in evidence-based biomedical research and collaboration across multiple clinical specialties, contributing to improved understanding of disease mechanisms and patient care.[2]

Keywords

Biology and Life Sciences; Clinical Medicine; Biomarkers; Artificial Intelligence; Women’s Health; Cardiovascular Risk; Medical Research.

Introduction

Modern biomedical research increasingly combines clinical observations with computational analysis to improve diagnosis and treatment. MEHMET KIVRAK has participated in investigations involving pregnancy-related disorders, polycystic ovary syndrome, dermatological diseases, and neurodevelopmental conditions. These studies illustrate an interdisciplinary approach integrating laboratory findings with clinical outcomes.[3]

Research Profile

According to the available author metrics, the researcher has produced 22 indexed documents receiving 92 citations with an h-index of 4. The research emphasizes prospective observational studies, biomarker evaluation, clinical epidemiology, and the application of explainable artificial intelligence to healthcare datasets. These activities reflect continued participation in internationally indexed scientific publishing.[1]

Research Contributions

  • Clinical investigations of hypertensive disorders during pregnancy and urinary health.
  • Evaluation of inflammatory biomarkers including IL-39 in polycystic ovary syndrome.
  • Explainable artificial intelligence for cardiovascular risk prediction in psoriasis.
  • Clinical follow-up studies examining ADHD treatment outcomes and emotional regulation.

Publications

  • Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy (2026).
  • Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome (2026).
  • Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence (2026).
  • Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD (2026).
  • Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı (2025).

Research Impact

The publication record demonstrates continuing contributions to clinical medicine and life sciences through peer-reviewed journals. Research outputs support understanding of women’s health, inflammatory mechanisms, predictive analytics, and evidence-based patient management. Citation activity indicates scholarly visibility and growing engagement within the international biomedical research community.[4]

Award Suitability

The research profile aligns with the objectives of the Global Innovation Technologist Awards by demonstrating interdisciplinary scientific investigation, peer-reviewed publication activity, and contributions to translational biomedical research. The combination of clinical expertise and emerging analytical methodologies represents a suitable basis for academic recognition within innovation-focused award programs.[5]

Conclusion

MEHMET KIVRAK’s scholarly activities reflect an emphasis on clinically relevant biomedical research supported by peer-reviewed publications and measurable research metrics. The available evidence highlights sustained contributions to Biology and Life Sciences while promoting interdisciplinary approaches that integrate clinical investigation with innovative analytical techniques.

References

  1. Elsevier. Scopus Author Details: MEHMET KIVRAK, Author ID 57211715569.
    https://www.scopus.com/pages/authors/57211715569
  2. Journal of Clinical Medicine. Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy.
    https://doi.org/10.3390/jcm15114162
  3. Journal of Clinical Medicine. Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome.
    https://doi.org/10.3390/jcm15103958
  4. Biology. Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence.
    https://doi.org/10.3390/biology15070532
  5. Journal of Clinical Medicine. Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD.
    https://doi.org/10.3390/jcm15062401
  6. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı.
    https://doi.org/10.17517/ksutfd.1621762